Neonatal herpes simplex infection and the Three Musketeers

New England Journal of Medicine

Volumn 365, Issue 14, 2011, Pages 1338-1339

  Gershon, Anne A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PLACEBO;

ADVERSE OUTCOME; ANTIVIRAL THERAPY; BRAIN DAMAGE; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITIVE DEVELOPMENT; DEFENSE MECHANISM; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG WITHDRAWAL; EDITORIAL; EYE DISEASE; HERPES SIMPLEX; HUMAN; MENTAL DEVELOPMENT; MOUTH DISEASE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUTROPENIA; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SKIN DEFECT; SKIN DISEASE; SURVIVOR; TREATMENT DURATION; TREATMENT OUTCOME; VIROGENESIS; VIRUS RESISTANCE; VIRUS TRANSMISSION;

EID: 80053465708     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1107953     Document Type: Editorial

References (7)

1. Hussey GD, Klein MA. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 1990;323:160-4. (Pubitemid 20219944)
2. Sugerman DE, Barskey AE, Delea MG, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010;125:747-55.
3. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D - adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347:1652-61. (Pubitemid 35340783)
4. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
5. Kimberlin DW, Whitley RJ, Wan W, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011;365:1284-92.
6. Prober CG, Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med 1988;318:887-91. (Pubitemid 18090273)
7. Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996;15:247-54. (Pubitemid 26098476)